However, the appetite-suppressing effects of semaglutide GLP-1 are gradual and may not be immediately noticeable after your first injection
Kuwasawa-Iwasaki M, Io H, Muto M et al (2020) Effects of L-carnitine supplementation in patients receiving hemodialysis or peritoneal dialysis
Lifetime prevalence data in the United States from 2010 indicated that 2.7% of adolescents manifested eating disorders at some point in their lifetime, with females being more than twice as likely as males [Reference Merikangas, He and Burstein11]
Studies in cells and animals suggest that GLP-1s could improve outcomes in this group
This is not medication failure
For others, it may be lowering the dose to reduce side effects, cost, or treatment burden